title: [Anti-tumor effects of heiji (radix Astilbes chinensis].
abstract: The experimental results indicate that the herb Heiji is able to suppress the growth of transplantable tumor (S180) in mice by 30%-51% (P < 0.01), prolong the vital stage of the EAC transplanted mice by 44% (P < 0.01) and raise the lymphocyte transformation rate in lower concentrations in vivo. It follows that Heiji has positive anti-tumor effects and deserves further research as a new anti-tumor herb.
authors.affiliation: Zhejiang College of Traditional Chinese Medicine, Hangzhou.
authors.forename: P
authors.initials: P
authors.lastname: Chen
authors.forename: P
authors.initials: P
authors.lastname: Lai
authors.forename: P
authors.initials: P
authors.lastname: Zhang
authors.forename: L
authors.initials: L
authors.lastname: Chen
authors.forename: A
authors.initials: A
authors.lastname: Li
mesh_terms: D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D008213:Lymphocyte Activation / Q000187:drug effects*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D012510:Sarcoma 180 / Q000188:drug therapy*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D004365:Drugs, Chinese Herbal